Advertisement
Singapore markets closed

  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Bitcoin USD

    63,880.64
    -2,467.62 (-3.72%)
     

  • CMC Crypto 200

    1,362.77
    -19.80 (-1.43%)
     

  • FTSE 100

    8,089.69
    +49.31 (+0.61%)
     

  • Gold

    2,338.40
    0.00 (0.00%)
     

  • Crude Oil

    82.66
    -0.15 (-0.18%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     

  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     

  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

EU regulators to rule on Mylan's $7.2 billion Meda bid by July 6

Reuters

BRUSSELS - European Union antitrust regulators will rule by July 6 whether to allow U.S. generic drugmaker Mylan NV (MYL.O) to buy Swedish peer Meda (MEDAa.ST) or open a full-scale investigation.

Mylan, which is making its third takeover attempt, sought EU approval on June 1, according to a filing on the European Commission website on Thursday.

The company can submit concessions in the preliminary review should the Commission express competition concerns. Some firms, however, prefer to wait for an extensive investigation so that they can tailor concessions to address specific worries.

(Reporting by Foo Yun Chee; editing by Jason Neely)